Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Neurosurgery
|
August 1, 1997
Application of antisense ribonucleic acid complementary to O6-methylguanine-deoxyribonucleic acid methyltransferase messenger ribonucleic acid for therapy of malignant gliomas
M Nagane, A Asai, S Shibui, et al.
Cancer Letters
|
February 13, 2001
Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications
M Nagane, H Lin, W K Cavenee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 29, 1997
Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189
S Y Cheng, M Nagane, H S Huang, et al.
Japanese Journal of Clinical Oncology
|
June 1, 1992
Expression of O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea resistance of human brain tumors
M Nagane, A Asai, S Shibui, et al.
Surgical Neurology
|
March 1, 1996
Triple primary malignant neoplasms including a malignant brain tumor: report of two cases and review of the literature
M Nagane, S Shibui, R Nishikawa, et al.
Surgical Neurology
|
November 1, 1995
Investigation of chemoresistance-related genes mRNA expression for selecting anticancer agents in successful adjuvant chemotherapy for a case of recurrent glioblastoma
M Nagane, S Shibui, H Oyama, et al.
Brain Tumor Pathology
|
March 23, 2002
Phenotypic changes associated with exogenous expression of p16INK4a in human glioma cells
A Noguchi, N Ito, H Sawa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 1998
Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases
M Nagane, A Levitzki, A Gazit, et al.
Japanese Journal of Clinical Oncology
|
March 18, 2000
Expression pattern of chemoresistance-related genes in human malignant brain tumors: a working knowledge for proper selection of anticancer drugs
M Nagane, A Asai, S Shibui, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
March 13, 1999
Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro
O Bögler, M Nagane, J Gillis, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Neurosurgery
|
August 1, 1997
Application of antisense ribonucleic acid complementary to O6-methylguanine-deoxyribonucleic acid methyltransferase messenger ribonucleic acid for therapy of malignant gliomas
M Nagane, A Asai, S Shibui, et al.
Cancer Letters
|
February 13, 2001
Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications
M Nagane, H Lin, W K Cavenee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 29, 1997
Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189
S Y Cheng, M Nagane, H S Huang, et al.
Japanese Journal of Clinical Oncology
|
June 1, 1992
Expression of O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea resistance of human brain tumors
M Nagane, A Asai, S Shibui, et al.
Surgical Neurology
|
March 1, 1996
Triple primary malignant neoplasms including a malignant brain tumor: report of two cases and review of the literature
M Nagane, S Shibui, R Nishikawa, et al.
Surgical Neurology
|
November 1, 1995
Investigation of chemoresistance-related genes mRNA expression for selecting anticancer agents in successful adjuvant chemotherapy for a case of recurrent glioblastoma
M Nagane, S Shibui, H Oyama, et al.
Brain Tumor Pathology
|
March 23, 2002
Phenotypic changes associated with exogenous expression of p16INK4a in human glioma cells
A Noguchi, N Ito, H Sawa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 20, 1998
Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases
M Nagane, A Levitzki, A Gazit, et al.
Japanese Journal of Clinical Oncology
|
March 18, 2000
Expression pattern of chemoresistance-related genes in human malignant brain tumors: a working knowledge for proper selection of anticancer drugs
M Nagane, A Asai, S Shibui, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
March 13, 1999
Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro
O Bögler, M Nagane, J Gillis, et al.
Page
of 4